Medical-Surgical Spinoff and Buybacks Could Be A Game Changer For McKesson (MCK)
McKesson Corporation recently reported its fourth-quarter and fiscal 2026 results, with quarterly sales of US$96,295 million and net income of US$1,682 million, alongside full-year sales of US$403.43 billion and net income of US$4.76 billion, while continuing sizable share repurchases under its long-running buyback program.
Beyond the headline numbers, McKesson is preparing to separate its Medical-Surgical Solutions segment and is bolstering capital returns, moves that could reshape how...
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
